In general, whether the vasculoprotective action of GLP1-RAs is mainly attributed to local GLP-1R stimulation or the peripheral effects that improve atherosclerosis is yet to be elucidated [31, 32]; however, the anti-inflammatory properties of this drug class indisputably play a pivotal role. The gene discussed is GLP1R; the disease is atherosclerosis.